Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.46 |
| ▸ | CA2 | P00918 | 4/20 | 0.46 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.45 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.45 |
| ▸ | IDO1 | P14902 | 1/20 | 0.44 |
| ▸ | CTSS | P25774 | 1/20 | 0.44 |
| ▸ | CTSK | P43235 | 1/20 | 0.44 |
| ▸ | SIGMAR1 | Q99720 | 2/20 | 0.43 |
| ▸ | FPR3 | P25089 | 4/20 | 0.43 |
| ▸ | FPR2 | P25090 | 4/20 | 0.43 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | GLA | P06280 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.43 |
| ▸ | CA12 | O43570 | 2/20 | 0.43 |
| ▸ | CA9 | Q16790 | 2/20 | 0.43 |
| ▸ | NAMPT | P43490 | 1/20 | 0.42 |
| ▸ | SUCNR1 | Q9BXA5 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 1/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23728795 | 0.89 | CA1 (0.47) | CA1CA2DDB1CRBNIDO1 | |
| SCHEMBL2551512 | 0.88 | CA1 (0.53) | CA1CA2CTSSCTSKSIGMAR1 | |
| SCHEMBL21482939 | 0.87 | TDP1 (0.53) | CA1CA2CTSSCTSKSIGMAR1 | |
| SCHEMBL25301986 | 0.85 | IDO1 (0.47) | CA1CA2IDO1CTSSCTSK | |
| SCHEMBL1065312 | 0.85 | CA2 (0.55) | CA1CA2CTSSCTSKFPR3 | |
| SCHEMBL20506786 | 0.84 | CA2 (0.54) | CA1CA2DDB1CRBNIDO1 | |
| SCHEMBL31584155 | 0.82 | CA12 (0.60) | CA1CA2IDO1FPR3FPR2 | |
| SCHEMBL30958195 | 0.81 | IDO1 (0.48) | CA1CA2IDO1CA12CA9 | |
| SCHEMBL24812650 | 0.80 | CA1 (0.54) | CA1CA2DDB1CRBNIDO1 | |
| SCHEMBL25772085 | 0.79 | SIGMAR1 (0.56) | CA1CA2IDO1SIGMAR1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | SDG, LLC | 2023-11-30 | — | — | US | disclosed |
| US-11666654-B2 | Drug delivery system for treating disease | SDG LLC (US) | 2023-06-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11666654-B2 | Drug delivery system for treating disease | HPGDS, VHL, HPSE | CA1 1007/4885CA2 636/4885DDB1 4596/4885 |
| US-20230381326-A1 | DRUG DELIVERY SYSTEM FOR TREATING DISEASE | HPGDS, VHL, HPSE | CA1 1007/4885CA2 636/4885DDB1 4596/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.